Last reviewed · How we verify
NCT05769413
Awareness of Osteoporosis in HIV Patients
trial testing Patient Participation Form in Human Immunodeficiency Virus Infection in 400 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | Uskudar State Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 August 2023 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 August 2024 |
Drugs / interventions tested
- Patient Participation Form
Conditions studied
- Human Immunodeficiency Virus Infection — all drugs for Human Immunodeficiency Virus Infection →
- Osteoporosis — all drugs for Osteoporosis →
- Osteoporosis Risk — all drugs for Osteoporosis Risk →
Sponsor
Uskudar State Hospital
Who can join
Adults 18 to 90, any sex, with Human Immunodeficiency Virus Infection or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Patients with human immunodeficiency virus infection are at increased risk for developing osteoporosis. Identifying whether patients with human immunodeficiency virus infection have information and awareness about this disease is crucial. This study is aimed to investigate awareness and knowledge of osteoporosis in patients with human immunodeficiency virus infection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessment of osteoporosis awareness and knowledge levels in people living with HIV.
Sarikaya B, Temel MH, Ata E, Aydin Sarikaya V, et al · · 2025 · PMID 40105551 · DOI 10.1590/1806-9282.20240925
Verify or expand the search:
- PubMed search for NCT05769413
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Patient Participation Form
Trials testing the same drug.
- NCT05760105 — Awareness of Osteoporosis in Ankylosing Spondylosis Patients · unknown
- NCT05760651 — Awareness of Osteoporosis in Multiple Sclerosis Patients · completed
- NCT05760417 — Awareness of Osteoporosis in Patients With Hyperthyroidism · unknown
- NCT05768737 — Awareness of Osteoporosis in Patients With Hepatitis B Infection · unknown
- NCT05769400 — Awareness of Osteoporosis in Patients With Hepatitis C Infection · unknown
Other Uskudar State Hospital trials
Trials by the same sponsor.
- NCT05760105 — Awareness of Osteoporosis in Ankylosing Spondylosis Patients · unknown
- NCT05882838 — The Level of Knowledge and Awareness of Myofascial Pain Syndrome in the Turkish Population · unknown
- NCT05760651 — Awareness of Osteoporosis in Multiple Sclerosis Patients · completed
- NCT05883215 — Effects of Social Media Usage on Pain Catastrophizing and Disease Impact in Female Patients With Fibromyalgia Syndrome · unknown
- NCT05738785 — Risk of Osteoporotic Fracture in Home Care Patients in Turkey · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05769413 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uskudar State Hospital
- Last refreshed: 23 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05769413.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing